KRRO - Korro Bio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$19.57
DETAILS
HIGH:
$30.00
LOW:
$10.00
MEDIAN:
$22.00
CONSENSUS:
$19.57
UPSIDE:
68.56%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 33.0% |
| EBIT Margin | -1366.4% |
| EBITDA Margin | -1299.5% |
| Operating Margin | -1366.4% |
| Pretax Margin | -1824.5% |
| Cont. Ops Margin | -1834.5% |
| Net Margin | -1834.5% |
| Bottom Line Margin | -1834.5% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 6.90 |
| Quick Ratio | 6.90 |
| Solvency Ratio | -1.820 |
| Cash Ratio | 1.83 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-0.64
Peers avg: 45.6
|
| PEG Ratio | -0.02 |
| Forward PEG | -0.02 |
| Price/Book | 1.46 |
| Price/Sales | 11.77 |
| Price/FCF | -0.95 |
| Price/Op Cash Flow | -0.96 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.3831 |
| Debt/Equity | 0.8454 |
| Debt/Capital | 0.4581 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 2.21 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.07 |
| Operating Cash Flow Ratio | -6.581 |
| Operating Cash Flow/Sales | -1229.1% |
| Free Cash Flow/Operating Cash Flow | 100.7% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -31.32 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -29.40 |
| Operating Cash Flow Coverage | -1.81 |
| Capital Expenditure Coverage | -151.66 |
| Dividend + Capital Expenditure Coverage | -151.66 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.68 |
| EPS | -12.481 |
| Debt/Share | 4.6284 |
| Cash/Share | 8.00 |
| Book Value/Share | 5.47 |
| Tangible BV/Share | 5.47 |
| Equity/Share | 5.47 |
| Operating Cash Flow/Share | -8.362 |
| Capital Expenditure/Share | 0.055 |
| FCF/Share | -8.417 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.005 |
| Earnings Before Tax/EBIT | 1.335 |
| Price/Fair Value | 1.46 |
| Debt/Market Cap | 0.0355 |
| Effective Tax Rate | -0.5% |
| Enterprise Value Multiple | -1.17 |